Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus

Sialic-acid-binding immunoglobulin-like lectin (siglec) regulates cell death, anti-proliferative effects and mediates a variety of cellular activities. Little was known about the relationship between siglecs and hepatocellular carcinoma (HCC) prognosis. Siglec gene expression between tumor and non-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiaojing, Ji, Yuanyuan, Jiang, Xuhua, Qi, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259014/
https://www.ncbi.nlm.nih.gov/pubmed/30355653
http://dx.doi.org/10.1042/BSR20181423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259014/
https://www.ncbi.nlm.nih.gov/pubmed/30355653
http://dx.doi.org/10.1042/BSR20181423

Ejemplares similares